Literature DB >> 26045556

Structural Basis of Clade-specific Engagement of SAMHD1 (Sterile α Motif and Histidine/Aspartate-containing Protein 1) Restriction Factors by Lentiviral Viral Protein X (Vpx) Virulence Factors.

Ying Wu1, Leonardus M I Koharudin1, Jennifer Mehrens1, Maria DeLucia1, Chang-Hyeok Byeon1, In-Ja L Byeon1, Guillermo Calero1, Jinwoo Ahn2, Angela M Gronenborn3.   

Abstract

Sterile α motif (SAM) and histidine/aspartate (HD)-containing protein 1 (SAMHD1) restricts human/simian immunodeficiency virus infection in certain cell types and is counteracted by the virulence factor Vpx. Current evidence indicates that Vpx recruits SAMHD1 to the Cullin4-Ring Finger E3 ubiquitin ligase (CRL4) by facilitating an interaction between SAMHD1 and the substrate receptor DDB1- and Cullin4-associated factor 1 (DCAF1), thereby targeting SAMHD1 for proteasome-dependent down-regulation. Host-pathogen co-evolution and positive selection at the interfaces of host-pathogen complexes are associated with sequence divergence and varying functional consequences. Two alternative interaction interfaces are used by SAMHD1 and Vpx: the SAMHD1 N-terminal tail and the adjacent SAM domain or the C-terminal tail proceeding the HD domain are targeted by different Vpx variants in a unique fashion. In contrast, the C-terminal WD40 domain of DCAF1 interfaces similarly with the two above complexes. Comprehensive biochemical and structural biology approaches permitted us to delineate details of clade-specific recognition of SAMHD1 by lentiviral Vpx proteins. We show that not only the SAM domain but also the N-terminal tail engages in the DCAF1-Vpx interaction. Furthermore, we show that changing the single Ser-52 in human SAMHD1 to Phe, the residue found in SAMHD1 of Red-capped monkey and Mandrill, allows it to be recognized by Vpx proteins of simian viruses infecting those primate species, which normally does not target wild type human SAMHD1 for degradation.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  SAM domain and HD domain-containing protein 1 (SAMHD1); SIV; X-ray crystallography; human immunodeficiency virus (HIV); nuclear magnetic resonance (NMR); restriction factor; ubiquitylation (ubiquitination)

Mesh:

Substances:

Year:  2015        PMID: 26045556      PMCID: PMC4505041          DOI: 10.1074/jbc.M115.665513

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses.

Authors:  Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2010-07-22       Impact factor: 21.023

3.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

Review 4.  The restriction factors of human immunodeficiency virus.

Authors:  Reuben S Harris; Judd F Hultquist; David T Evans
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

Review 5.  β-TrCP dependency of HIV-1 Vpu-induced downregulation of CD4 and BST-2/tetherin.

Authors:  Fabien P Blanchet; J P Mitchell; Vincent Piguet
Journal:  Curr HIV Res       Date:  2012-06       Impact factor: 1.581

6.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

7.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

8.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.

Authors:  Kasia Hrecka; Caili Hao; Magda Gierszewska; Selene K Swanson; Malgorzata Kesik-Brodacka; Smita Srivastava; Laurence Florens; Michael P Washburn; Jacek Skowronski
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

Review 9.  Molecular mechanisms of HIV immune evasion of the innate immune response in myeloid cells.

Authors:  Mike Mashiba; Kathleen L Collins
Journal:  Viruses       Date:  2012-12-21       Impact factor: 5.048

10.  Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.

Authors:  Sara L Sawyer; Michael Emerman; Harmit S Malik
Journal:  PLoS Biol       Date:  2004-07-20       Impact factor: 8.029

View more
  5 in total

1.  The C-terminal domain of feline and bovine SAMHD1 proteins has a crucial role in lentiviral restriction.

Authors:  Chu Wang; Kaikai Zhang; Lina Meng; Xin Zhang; Yanan Song; Ying Zhang; Yanxin Gai; Yuepeng Zhang; Bin Yu; Jiaxin Wu; Song Wang; Xianghui Yu
Journal:  J Biol Chem       Date:  2020-02-19       Impact factor: 5.157

2.  The DDB1-DCAF1-Vpr-UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction.

Authors:  Ying Wu; Xiaohong Zhou; Christopher O Barnes; Maria DeLucia; Aina E Cohen; Angela M Gronenborn; Jinwoo Ahn; Guillermo Calero
Journal:  Nat Struct Mol Biol       Date:  2016-08-29       Impact factor: 15.369

Review 3.  Functional organization of human SAMHD1 and mechanisms of HIV-1 restriction.

Authors:  Jinwoo Ahn
Journal:  Biol Chem       Date:  2016-04       Impact factor: 3.915

4.  HIV-1 Vpr activates host CRL4-DCAF1 E3 ligase to degrade histone deacetylase SIRT7.

Authors:  Xiaohong Zhou; Christina Monnie; Maria DeLucia; Jinwoo Ahn
Journal:  Virol J       Date:  2021-03-01       Impact factor: 4.099

5.  Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV.

Authors:  Jordan Wilkins; Yi-Min Zheng; Jingyou Yu; Chen Liang; Shan-Lu Liu
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.